Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (20)

2022

  1. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

2020

  1. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease

    Quality of Life Research, Vol. 29, Núm. 3, pp. 607-617

  2. Corrigendum to “Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample” (Drug and Alcohol Dependence (2018) 187 (358–362), (S0376871618302096), (10.1016/j.drugalcdep.2018.03.013))

    Drug and Alcohol Dependence

2019

  1. ADGRL3 (LPHN3) variants predict substance use disorder

    Translational Psychiatry, Vol. 9, Núm. 1

  2. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 9, pp. 579-592

  3. The more you take it, the better it works: Six-month results of a nalmefene phase-IV trial

    Journal of Clinical Medicine, Vol. 8, Núm. 4

2018

  1. Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample

    Drug and Alcohol Dependence, Vol. 187, pp. 358-362

  2. Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

    Clinical Drug Investigation

  3. Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results

    Clinical Drug Investigation, Vol. 38, Núm. 2, pp. 147-155

2017

  1. Association of the PLCB1 gene with drug dependence

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence

    Scientific Reports, Vol. 6

  2. Clinical differences between cocaine-dependent patients with and without antisocial personality disorder

    Psychiatry Research, Vol. 246, pp. 587-592

  3. Diferencias relevantes en la percepción y el grado de conocimiento de los profesionales de las distintas Comunidades Autónomas españolas sobre la existencia de recursos para pacientes con patología dual

    Actas Espanolas de Psiquiatria, Vol. 44, Núm. 1, pp. 1-12

2015

  1. Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence

    Translational Psychiatry, Vol. 5, Núm. 10

2013

  1. Association study of 37 genes related to serotonin and dopamine neurotransmission and neurotrophic factors in cocaine dependence

    Genes, Brain and Behavior, Vol. 12, Núm. 1, pp. 39-46

  2. Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs)

    European Neuropsychopharmacology, Vol. 23, Núm. 11, pp. 1463-1473

  3. Lack of association between the LPR and VNTR polymorphisms of the serotonin transporter gene and cocaine dependence in a Spanish sample

    Psychiatry Research, Vol. 210, Núm. 3, pp. 1287-1289

2012

  1. Candidate pathway association study in cocaine dependence: The control of neurotransmitter release

    World Journal of Biological Psychiatry, Vol. 13, Núm. 2, pp. 126-134

2010

  1. Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample

    Psychiatric Genetics, Vol. 20, Núm. 6, pp. 317-320

2003

  1. The integral care programme for sick physicians (PAIMM) of the medical council of Barcelona

    DUAL DIAGNOSIS: FILLING THE GAP